A Multicenter, Randomized, Double-Blind, Comparative Trial Of Maraviroc + Darunavir/Ritonavir Versus Emtricitabine/Tenofovir + Darunavir/Ritonavir For The Treatment Of Antiretroviral-Naive Hiv-Infected Patients With Ccr5-Tropic Hiv-1
收藏DataCite Commons2024-11-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009196/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess whether maraviroc administered once daily is
non-inferior to emtricitabine/tenofovir also administered once daily each in combination with
darunavir/ritonavir in the treatment of antiretroviral-naive patients as evaluated at Week 48
of treatment.
提供机构：
Vivli
创建时间：
2023-08-15
